Background: Chronic obstructive pulmonary disease (COPD) is a debilitating disease and
places a large financial burden on health-care systems and society. We prospectively …

Purpose To evaluate fluticasone propionate/formoterol (FP/FORM) in COPD. Patients and
methods COPD patients with forced expiratory volume in 1 s (FEV1)≤ 50% predicted and≥ …

Objectives: To determine the effect of long term inhaled corticosteroids on lung function,
exacerbations, and health status in patients with moderate to severe chronic obstructive …

Exacerbations of chronic obstructive pulmonary disease (COPD) are associated with worse
health and increased healthcare utilisation. The Inhaled Steroids in Obstructive Lung …

Background The efficacy of inhaled corticosteroids in the treatment of chronic obstructive
pulmonary disease (COPD) remains controversial because of a lack of placebo-controlled …

OBJECTIVE: We examine the lifetime cost-effectiveness of treatment with fluticasone
propionate/salmeterol (500/50μg) compared with no maintenance treatment in COPD in the …

BACKGROUND:: The pathology of chronic obstructive pulmonary disease (COPD) includes
both obstructive and inflammatory components. OBJECTIVE:: The aim of this study was to …

Purpose Relative costs and utilization-related outcomes of a fluticasone propionate 250 μg+
salmeterol 50 μg combination (FSC), tiotropium bromide, and ipratropium as initial …

Background Evidence for the management of chronic obstructive pulmonary disease
(COPD) comes from closely monitored efficacy trials involving groups of patients who were …

Inhaled corticosteroids are often used in the treatment of stable chronic obstructive
pulmonary disease (COPD), however, studies of these agents have had mixed results …